Persistence of low disease activity after tumour necrosis factor inhibitor (TNFi) discontinuation in patients with psoriatic arthritis.

Huynh, D H; Boyd, T A; Etzel, C J; Cox, V; Kremer, J; Mease, P; Kavanaugh, A

Huynh, D H; Boyd, T A; Etzel, C J; Cox, V; Kremer, J; Mease, P; Kavanaugh, A.

Afiliación

Huynh DH; Allergy and Rheumatology Clinic , La Jolla, California , USA.
Boyd TA; Division of Rheumatology, Department of Medicine , Western University , London, Ontario , Canada.
Etzel CJ; Corrona LLC , Southborough, Massachusetts , USA.
Cox V; Corrona LLC , Southborough, Massachusetts , USA.
Kremer J; Corrona LLC , Southborough, Massachusetts , USA.
Mease P; Swedish Medical Center and University of Washington , Seattle, Washington , USA.
Kavanaugh A; Division of Rheumatology, Allergy and Immunology, University of California, San Diego, California, USA; School of Medicine, La Jolla, California, USA.

RMD Open ; 3(1): e000395, 2017.

Article en En | MEDLINE | ID: mdl-28123783

Palabras clave

Anti-TNF; Disease Activity; Psoriatic Arthritis; Treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: RMD Open Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google